1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,860 | 3,920 | 17:19 | |
| 3,860 | 3,920 | 17:19 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| FORTREA Aktie jetzt für 0€ handeln | |||||
| 14.05. | Fortrea stock price target lowered to $8 by Mizuho | 4 | Investing.com | ||
| 13.05. | Beyond The Numbers: 6 Analysts Discuss Fortrea Holdings Stock | 8 | Benzinga.com | ||
| 12.05. | Fortrea Holdings Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 12.05. | Fortrea reaffirms $2.45B-$2.55B revenue guidance for 2025 as transformation efforts progress | 2 | Seeking Alpha | ||
| 12.05. | Fortrea Q1 2025 slides: $489M impairment charge overshadows EBITDA growth | 4 | Investing.com | ||
| 12.05. | Fortrea CEO Thomas Pike to step down | 3 | Seeking Alpha | ||
| 12.05. | Fortrea beats Q1 estimates | 2 | Seeking Alpha | ||
| 12.05. | Fortrea Holdings Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | Fortrea Holdings Inc: Fortrea Reports First Quarter 2025 Results | 179 | GlobeNewswire (Europe) | For the three months ended March 31, 2025, from continuing operations: Revenues of $651.3 millionGAAP net loss of $(562.9) million, inclusive of a non-cash goodwill impairment chargeAdjusted EBITDA... ► Artikel lesen | |
| 12.05. | Fortrea Holdings Inc: Fortrea Announces CEO Stepping Down | 214 | GlobeNewswire (Europe) | DURHAM, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that Thomas Pike is stepping down from... ► Artikel lesen | |
| 01.05. | Truist sets Fortrea stock with Hold rating, $7 target | 3 | Investing.com | ||
| 01.05. | Fortrea Holdings Inc: Fortrea Named a Leader in Everest Group's Pharmacovigilance Operations PEAK Matrix Assessment 2025 | 2 | GlobeNewswire (USA) | ||
| 10.04. | Iqvia, Icon, Fortrea downgraded at Barclays on tariff overhang | 20 | Seeking Alpha | ||
| 10.04. | Barclays cuts Fortrea stock rating, halves price target to $6 | 7 | Investing.com | ||
| 09.04. | Demystifying Fortrea Holdings: Insights From 4 Analyst Reviews | 5 | Benzinga.com | ||
| 17.03. | Fortrea's credit rating downgraded by Fitch due to weakening profile | 4 | Investing.com | ||
| 10.03. | Fortrea Holdings Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.03. | Fortrea stock target cut to $11 at TD Cowen, maintains hold | 1 | Investing.com | ||
| 03.03. | Fortrea stock target cut to $12 at Citi on 2025 guidance miss | 3 | Investing.com | ||
| 03.03. | Fortrea Holdings Inc. - 10-K, Annual Report | 8 | SEC Filings |
Seite:
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BB BIOTECH | 32,650 | +1,71 % | BB Biotech - Optimistic about biotech's long-term prospects | During 2024 and early this year, the biotech sector began to show signs of a structural recovery, supported by positive clinical data, regulatory approvals, lower interest rates, commercial execution... ► Artikel lesen | |
| QIAGEN | 39,805 | +0,89 % | Kursgewinne für die Qiagen NV-Aktie (38,655 €) | Die Aktie von Qiagen NV notiert am Dienstag etwas fester. Der jüngste Kurs betrug 38,66 Euro. Die Qiagen NV-Aktie verzeichnet aktuell ein Kursplus von 2,76 Prozent. Sie hat sich um 1,04 Euro gegenüber... ► Artikel lesen | |
| NOVAVAX | 6,316 | +2,17 % | Schock-News für Novavax Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| STRYKER | 334,70 | +0,57 % | Is Stryker Stock Underperforming the Nasdaq? | ||
| ILLUMINA | 71,62 | +1,06 % | Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? | ||
| CRISPR THERAPEUTICS | 33,400 | +3,09 % | AKTIONÄR-Depotwert CRISPR Therapeutics: Cathie Wood kauft erneut | Die Aktie des Gen-Schere-Spezialisten CRISPR Therapeutics kommt seit Monaten nicht von der Stelle. Das aktuelle Niveau hat nun aber Cathie Wood zum Kauf genutzt. Die für Donnerstag veröffentlichten... ► Artikel lesen | |
| AAP IMPLANTATE | 1,260 | 0,00 % | EQS-AFR: aap Implantate AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: aap Implantate AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
aap Implantate AG: Vorabbekanntmachung... ► Artikel lesen | |
| OCUGEN | 0,736 | +1,27 % | Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST-Modifier Gene Therapy for the Treatment of Stargardt Disease | MALVERN, Pa., May 27, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that... ► Artikel lesen | |
| SANGAMO THERAPEUTICS | 0,450 | +10,84 % | Sangamo stock holds $10 target from H.C. Wainwright on trial optimism | ||
| INTELLIA THERAPEUTICS | 6,650 | +6,37 % | Canaccord Genuity lowers Intellia stock price target to $54 | ||
| SCORPIUS | 0,050 | 0,00 % | Scorpius Holdings, Inc.: Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia | Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia San Antonio, TX, May 04, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| EDITAS MEDICINE | 1,507 | -2,33 % | Editas Medicine ändert Aktienplan und erhöht genehmigte Aktien | ||
| DEFENCE THERAPEUTICS | 0,488 | -1,41 % | Defence Therapeutics Inc.: Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub | Montreal, Quebec--(Newsfile Corp. - June 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in advanced... ► Artikel lesen | |
| BIOCRYST PHARMACEUTICALS | 9,474 | +1,00 % | BioCryst Pharmaceuticals, Inc.: BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted... ► Artikel lesen | |
| KUROS BIOSCIENCES | 26,340 | -5,46 % | Kuros Biosciences AG: Kuros Biosciences to share latest MagnetOs market impact and strategic priorities at Capital Market Day in Zürich | Kuros Biosciences to share latest MagnetOs market impact and strategic priorities at Capital Markets Day in Zürich
Schlieren (Zürich), Switzerland, May 13, 2025 - Kuros Biosciences ("Kuros"... ► Artikel lesen |
FORTREA HOLDINGS INC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von +0,060 (+1,66 %) liegt der Kurs bei 3,680 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FORTREA HOLDINGS INC finden Sie auf Wallstreet Online.